Literature DB >> 31447925

A case of sinus pause induced by swallowing in the setting of olanzapine and guanfacine overdose.

Andrew R Kolarich1, Matthew Mubarak2, Shannon Wells2, Christopher T Campbell3, Ravi S Samraj2.   

Abstract

Olanzapine, a second-generation antipsychotic, is used in both adult and pediatric populations for schizophrenia, bipolar disorder, and depression and has been associated with autonomic dysregulation in the setting of overdose. Guanfacine is a sympatholytic drug used in the treatment of attention deficit hyperactivity disorder and has also been associated with autonomic dysfunction. We present a unique case of a 17-year-old male who overdosed on 340 mg of olanzapine and 189 mg of extended-release guanfacine with a previously unreported adverse event. Specifically, five days after ingestion, he developed a 5-8 s sinus pause every time he forcefully swallowed any beverage, suggestive of a vagal hypersensitivity reaction. The report will review the autonomic dysfunction of olanzapine and guanfacine and management of asymptomatic sinus pause in the critical care setting.

Entities:  

Keywords:  Sinus arrest; attention deficit and disruptive behavior disorders; cardiac; drug overdose; guanfacine; olanzapine

Year:  2018        PMID: 31447925      PMCID: PMC6693107          DOI: 10.1177/1751143718786109

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  15 in total

Review 1.  Olanzapine overdose in children and adolescents: two case reports and a review of the literature.

Authors:  Frank M Theisen; Justyna Grabarkiewicz; Christine Fegbeutel; Anja Hübner; Claudia Mehler-Wex; Helmut Remschmidt
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-12       Impact factor: 2.576

2.  Guanfacine overdose in a pediatric patient.

Authors:  M W Van Dyke; A L Bonace; M J Ellenhorn
Journal:  Vet Hum Toxicol       Date:  1990-02

3.  Treatment of guanfacine toxicity with naloxone.

Authors:  Daniel S Tsze; Peter S Dayan
Journal:  Pediatr Emerg Care       Date:  2012-10       Impact factor: 1.454

4.  Guanfacine overdose resulting in initial hypertension and subsequent delayed, persistent orthostatic hypotension.

Authors:  Alicia B Minns; Richard F Clark; Aaron Schneir
Journal:  Clin Toxicol (Phila)       Date:  2010-02       Impact factor: 4.467

5.  The clinical picture of olanzapine poisoning with special reference to fluctuating mental status.

Authors:  Sandra Palenzona; Peter J Meier; Hugo Kupferschmidt; Christine Rauber-Luethy
Journal:  J Toxicol Clin Toxicol       Date:  2004

Review 6.  Safety and pharmacokinetics of atypical antipsychotics in children and adolescents.

Authors:  Silvio Caccia
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

7.  Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder.

Authors:  Samuel W Boellner; Michael Pennick; Kimberly Fiske; Andrew Lyne; Amir Shojaei
Journal:  Pharmacotherapy       Date:  2007-09       Impact factor: 4.705

8.  Sinus automaticity and sinoatrial conduction in severe symptomatic sick sinus syndrome.

Authors:  D L Wu; S J Yeh; F C Lin; C C Wang; W J Cherng
Journal:  J Am Coll Cardiol       Date:  1992-02       Impact factor: 24.094

9.  An overdose of extended-release guanfacine.

Authors:  Daniel M Fein; Zoabe F Hafeez; Christopher Cavagnaro
Journal:  Pediatr Emerg Care       Date:  2013-08       Impact factor: 1.454

Review 10.  A review of olanzapine-associated toxicity and fatality in overdose.

Authors:  Pierre Chue; Peter Singer
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

View more
  1 in total

1.  Delayed Signs and Symptoms of Extended Release Guanfacine Overdose in Two Adolescent Patients: Implications of Monitoring on the Psychiatry Unit.

Authors:  Sanskriti Mishra; Julia Shekunov; Della J Derscheid; Elizabeth A Canterbury; Jonathan G Leung
Journal:  Case Rep Psychiatry       Date:  2022-03-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.